Cited by 68melanin and skin pigmentationDermatologic Treatments and ResearchMelanoma and MAPK Pathways

Novel Anti-Melanogenesis Properties of Polydeoxyribonucleotide, a Popular Wound Healing Booster

Open access
Noh, Tai, Chung, Bo, Kim, Su, Lee, Mi, Kim, Moon, Youn, Choon, Lee, Mi, Chang, Sung·2016·International Journal of Molecular Sciences

Abstract

Polydeoxyribonucleotide (PDRN), a deoxyribonucleotide polymer, is popularly used for faster healing of cutaneous wounds and boosting of neocollagenesis of photoaged skin among current dermatologic practitioners. Some patients receiving PDRN injection treatment also reported improvement of photoaging-associated mottled pigmentation (PMP). To investigate the effect of PDRN on cutaneous melanogenesis, we examined the effect of PDRN and an available product (Placentex®) containing PDRN on melanogenesis using human melanocytes-keratinocytes cocultures and mouse melanocytes. Melanin content, tyrosinase activity, and levels of microphthalmia-associated transcription factor (MITF), tyrosinase, and tyrosinase-related protein (TRP-1) were determined. Intracellular signaling pathways were assessed by Western blotting. PDRN and Placentex® led to decreases in melanin content, tyrosinase activity, and MITF and TRP-1 expression with concomitant increases in phosphorylated forms of extracellular signal-regulated protein kinase (ERK) and AKT in mouse melanocytes. More importantly, both PDRN and Placentex® significantly suppressed the melanin content in human melanocyte–keratinocyte cocultures. Clinical evaluation of six female patients with facial hyperpigmentation after three sessions of intradermal PDRN injections using a 5-point scale revealed that PDRN led to more than noticeable improvements in hyperpigmented lesions. This is the first study to demonstrate that PDRN, which is known for its wound-healing properties, may have novel anti-melanogenesis and potential skin whitening properties.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms17091448

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PDRN induces hypopigmentation by inhibiting melanogenesis through downregulation of melanogenic gene expression and suppression of tyrosinase activity.

    “PDRN induces hypopigmentation by inhibiting melanogenesis through downregulation of melanogenic gene expression and suppression of tyrosinase activity, the rate-limiting enzyme in melanin synthesis [101].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [101]

    Results §2.2 reports reduced intracellular tyrosinase activity, and Results §2.3 reports reduced MITF, tyrosinase, and TRP-1 protein levels after PDRN treatment. These findings support suppressed melanogenesis, but the paper reports protein levels rather than directly demonstrating downregulation of melanogenic gene expression. Page numbers are not available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [2]Squadrito F. Bitto A. Altavilla D. Arcoraci V. de Caridi G. de Feo M.E. Corrao S. Pallio G. Sterrantino C. Minutoli L. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: Results of a clinical trial J. Clin. Endocrinol. Metab. 2014 99 E746 E753 10.1210/jc.2013-3569 24483158 · DOI

Cited by

Sorted by citations

Authors
Noh, T., Chung, B., Kim, S., Lee, M., Kim, M., Youn, C., Lee, M., & Chang, S.
Affiliations
  • Asan Medical Center (KR)
  • Hallym University Kangnam Sacred Heart Hospital (KR)
  • MJ All Skin Clinic, Seoul 04537, Korea
  • YeMiWon Clinic, Seoul 06280, Korea
Corresponding author
Chang, Sung
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2016-09-01
Volume
17
Issue
9
Pages
1448
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2507671702
Cited by
68
References
28
Citations by year
2026: 24 · 2025: 13 · 2024: 8 · 2023: 8 · 2022: 5 · 2021: 3 · 2019: 2 · 2018: 2 · 2017: 2 · 2014: 1
FWCI
1.37
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
polydeoxyribonucleotide, anti-melanogenesis, melanogenesis, skin lightening, hyperpigmentation, tyrosinase, MITF, TRP-1, ERK signaling, Akt signaling, intradermal injection, wound healing
MeSH terms
Adult, Aged, Animals, Cell Line, Female, Humans, Melanins, Melanocytes, Middle Aged, Polydeoxyribonucleotides, Skin Pigmentation, Trypsin, Monophenol Monooxygenase, Extracellular Signal-Regulated MAP Kinases, Proto-Oncogene Proteins c-akt, Mice, Microphthalmia-Associated Transcription Factor, Skin Lightening Preparations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review